Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.45% for the current model date.
BlackTreeCVE Intelligenceaiyiyi121 · SxDevOps
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableA vulnerability was determined in aiyiyi121 SxDevOps 1.0/1.1. This affects the function update of the file backend/rbac/serializers.py of the component UserSerializer. Executing a manipulation can lead to improper privilege management. The attack can be executed remotely. This patch is called 2b4bf8585c3e731e7a8af30801ea46680bc783f9. It is best practice to apply a patch to resolve this issue. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.
A vulnerability was determined in aiyiyi121 SxDevOps 1.0/1.1. This affects the function update of the file backend/rbac/serializers.py of the component UserSerializer. Executing a manipulation can lead to improper privilege management. The attack can be executed remotely. This patch is called 2b4bf8585c3e731e7a8af30801ea46680bc783f9. It is best practice to apply a patch to resolve this issue. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.
The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
A vulnerability was determined in aiyiyi121 SxDevOps 1.0/1.1. This affects the function update of the file backend/rbac/serializers.py of the component UserSerializer. Executing a manipulation can lead to improper privilege management. The attack can be executed remotely. This patch is called 2b4bf8585c3e731e7a8af30801ea46680bc783f9. It is best practice to apply a patch to resolve this issue. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.
The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-269: Improper Privilege Management. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:XCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 20 Sept 2026 · Last source change 21 Sept 2026, 18:09 UTC · CWE-269 · Improper Privilege Management
Core structured fields are present and their contributing authorities are shown above.